Petersen, Peter C., et al. “A Randomized Phase 2 Trial of First-Line Docetaxel, Carboplatin, Capecitabine (CTX) and Epirubicin, Oxaliplatin, Capecitabine (EOX) in Advanced Esophagogastric Adenocarcinoma”. Acta Oncologica, vol. 60, no. 7, July 2021, pp. 948-53, doi:10.1080/0284186X.2021.1928281.